CTOs on the Move

Pinetree Capital

www.pinetreecapital.com

 
Pinetree is a diversified investment, financial advisory and venture capital firm focused on investing in early stage micro and small cap resource companies. Pinetree`s investments are primarily in the following resource sectors: Precious Metals, Base Metals Oil and Gas, Potash, Lithium and Rare Earths, Uranium and Coal. Pinetree`s investment approach is to develop a macro view of a sector, build a position consistent with the view by identifying micro-cap opportunities within that sector and devise an exit strategy designed to maximize our relative return in light of changing fundamentals and opportunities. Pinetree is recognized as a value added partner in ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

American Orthodontics

American Orthodontics is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. American Orthodontics is based in Sheboygan, WI. You can find more information on American Orthodontics at www.americanortho.com

Benchmark Research

Benchmark Research is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pointe Scientific

Pointe Scientific is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

My Brother's Keeper

My Brother's Keeper is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kolltan

Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.